These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12597046)

  • 1. Sepsis and treatment-induced immunosuppression in the patient with cancer.
    Reigle BS; Dienger MJ
    Crit Care Nurs Clin North Am; 2003 Mar; 15(1):109-18. PubMed ID: 12597046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The occurrence of cancer in immune deficiencies.
    Penn I
    Curr Probl Cancer; 1982 Apr; 6(10):1-64. PubMed ID: 7105828
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters.
    Howell PB; Walters PE; Donowitz GR; Farr BM
    Cancer; 1995 Mar; 75(6):1367-75. PubMed ID: 7882288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sepsis and the septic shock in oncological or other immunocompromised patients--diagnosis, therapy].
    Navrátil M; Tomíska M; Korístek Z; Vorlícek J; Mayer J
    Vnitr Lek; 2010 Jun; 56(6):557-69. PubMed ID: 20681468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection in neutropenic patients with cancer.
    Bow EJ
    Crit Care Clin; 2013 Jul; 29(3):411-41. PubMed ID: 23830647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing oncology neutropenia and sepsis in the intensive care unit.
    Vioral AN; Wentley D
    Crit Care Nurs Q; 2015; 38(2):165-74. PubMed ID: 25741957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
    Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
    Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a Method to Identify Immunocompromised Patients with Severe Sepsis in Administrative Databases.
    Greenberg JA; Hohmann SF; Hall JB; Kress JP; David MZ
    Ann Am Thorac Soc; 2016 Feb; 13(2):253-8. PubMed ID: 26650336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nursing protocol for the patient with neutropenia.
    Brandt B
    Oncol Nurs Forum; 1990; 17(1 Suppl):9-15. PubMed ID: 2105483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis in the immunosuppressed patient.
    Miller WT
    Semin Roentgenol; 1979 Jul; 14(3):249-55. PubMed ID: 314157
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention and treatment of cancer-related infections.
    Baden LR; Bensinger W; Angarone M; Casper C; Dubberke ER; Freifeld AG; Garzon R; Greene JN; Greer JP; Ito JI; Karp JE; Kaul DR; King E; Mackler E; Marr KA; Montoya JG; Morris-Engemann A; Pappas PG; Rolston K; Segal B; Seo SK; Swaminathan S; Naganuma M; Shead DA;
    J Natl Compr Canc Netw; 2012 Nov; 10(11):1412-45. PubMed ID: 23138169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cancer therapy and the immune response of the body].
    Bergol'ts VM
    Vopr Onkol; 1970; 16(12):82-93. PubMed ID: 4932064
    [No Abstract]   [Full Text] [Related]  

  • 13. Sepsis in the immunocompromised child: the least studied with the most to gain.
    Priebe GP
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S78-9. PubMed ID: 15864109
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on "impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with haematological malignancies" by Vandijck et al.
    Meyer S; Gortner L; Gottschling S
    Intensive Care Med; 2008 Oct; 34(10):1929; author reply 1930-1. PubMed ID: 18636240
    [No Abstract]   [Full Text] [Related]  

  • 15. Neonatal sepsis: pathogenesis and supportive therapy.
    Wolach B
    Semin Perinatol; 1997 Feb; 21(1):28-38. PubMed ID: 9190031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-control study to evaluate risk factors for the development of sepsis (neutropenia and fever) in dogs receiving chemotherapy.
    Sorenmo KU; Harwood LP; King LG; Drobatz KJ
    J Am Vet Med Assoc; 2010 Mar; 236(6):650-6. PubMed ID: 20225976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a rationale for the prophylactic prescription of hematopoietic colony-stimulating factor after a bacteriologically documented neutropenic infection?
    Thieblemont C; Frappaz D; Coullioud D; Fuhrmann C; Bouffet E; Brunat-Mentigny M; Philip T
    Pediatr Hematol Oncol; 1996; 13(5):473-5. PubMed ID: 10897821
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000.
    Castagnola E; Ruberto E; Guarino A
    World J Gastroenterol; 2016 Jul; 22(25):5853-66. PubMed ID: 27433098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing predisposition to sepsis in children with cancers and acquired immunodeficiencies unrelated to human immunodeficiency virus infection.
    Allen UD
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S80-6. PubMed ID: 15857564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiome mediation of infections in the cancer setting.
    Taur Y; Pamer EG
    Genome Med; 2016 Apr; 8(1):40. PubMed ID: 27090860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.